Louis Fries

8.3k total citations
77 papers, 3.5k citations indexed

About

Louis Fries is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Louis Fries has authored 77 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 28 papers in Infectious Diseases and 21 papers in Immunology. Recurrent topics in Louis Fries's work include Respiratory viral infections research (31 papers), Influenza Virus Research Studies (29 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Louis Fries is often cited by papers focused on Respiratory viral infections research (31 papers), Influenza Virus Research Studies (29 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Louis Fries collaborates with scholars based in United States, Canada and Belgium. Louis Fries's co-authors include Michael M. Frank, Gregory M. Glenn, Gale Smith, M L Clements, Martin Frank, Carl H. Hammer, Eloi Kpamegan, Somia P. Hickman, Hanxin Lu and Brian R. Murphy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Louis Fries

76 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Louis Fries United States	37	1.8k	1.1k	1.1k	568	500	77	3.5k
Darrick Carter United States	38	1.4k 0.8×	793 0.7×	1.2k 1.1×	1.2k 2.2×	1.0k 2.0×	110	4.0k
Richard T. Kenney United States	29	1.3k 0.7×	495 0.5×	1.1k 1.0×	557 1.0×	961 1.9×	59	3.2k
Kathy Hancock United States	30	2.6k 1.4×	1.0k 0.9×	763 0.7×	1.0k 1.8×	300 0.6×	68	4.7k
Geetha P. Bansal United States	17	1.4k 0.8×	1.6k 1.4×	674 0.6×	707 1.2×	209 0.4×	43	2.8k
Sven Britton Sweden	43	2.0k 1.1×	2.2k 2.0×	1.9k 1.8×	615 1.1×	669 1.3×	152	5.7k
Emanuele Montomoli Italy	38	2.8k 1.6×	2.1k 1.9×	1.3k 1.2×	940 1.7×	306 0.6×	210	5.1k
Robert J. Hogan United States	27	1.4k 0.8×	1.3k 1.1×	2.0k 1.9×	799 1.4×	153 0.3×	65	3.9k
Tetsuo Nakayama Japan	30	1.8k 1.0×	973 0.9×	393 0.4×	325 0.6×	211 0.4×	203	3.0k
Anke Huckriede Netherlands	37	1.6k 0.9×	822 0.7×	1.6k 1.6×	1.3k 2.4×	165 0.3×	117	4.0k
Michael Roggendorf Germany	45	5.0k 2.8×	1.6k 1.5×	1.5k 1.5×	684 1.2×	271 0.5×	225	7.0k

Countries citing papers authored by Louis Fries

Since Specialization

Citations

This map shows the geographic impact of Louis Fries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Fries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Fries more than expected).

Fields of papers citing papers by Louis Fries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Fries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Fries. The network helps show where Louis Fries may publish in the future.

Co-authorship network of co-authors of Louis Fries

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Fries. A scholar is included among the top collaborators of Louis Fries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Fries. Louis Fries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kalkeri, Raj, Mingzhu Zhu, Anand Parekh, et al.. (2025). Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform–specific priming and immune imprinting. Journal of Infection. 91(2). 106543–106543. 1 indexed citations

Martin, Daniel, Franz Rödel, Stephanie Hehlgans, et al.. (2024). Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma. npj Precision Oncology. 8(1). 93–93. 4 indexed citations

Stertman, Linda, Anna-Karin E. Palm, Berit Carow, et al.. (2023). The Matrix-M™ adjuvant: A critical component of vaccines for the 21 ^st century. Human Vaccines & Immunotherapeutics. 19(1). 2189885–2189885. 59 indexed citations

Zhu, Mingzhu, Shane Cloney-Clark, Anand Parekh, et al.. (2023). A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection. Microorganisms. 11(7). 1789–1789. 11 indexed citations

Levine, Min Z., Crystal Holiday, Yaohui Bai, et al.. (2022). Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population Immunity. Vaccines. 10(11). 1856–1856. 6 indexed citations

Shinde, Vivek, Rongman Cai, Joyce S. Plested, et al.. (2020). Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine. Clinical Infectious Diseases. 73(11). e4278–e4287. 20 indexed citations

Muñoz, Flor M., Geeta K. Swamy, Somia P. Hickman, et al.. (2019). Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants. The Journal of Infectious Diseases. 220(11). 1802–1815. 68 indexed citations

Glenn, Gregory M., Louis Fries, D. Nigel Thomas, et al.. (2015). A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age. The Journal of Infectious Diseases. 213(3). 411–422. 115 indexed citations

Glenn, Gregory M., Louis Fries, Gale Smith, et al.. (2015). Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs. Vaccine. 33(47). 6488–6492. 21 indexed citations

10.

Langley, Joanne M., Louise Frenette, Robert Jeanfreau, et al.. (2014). Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: A randomized controlled clinical trial. Vaccine. 33(4). 559–567. 16 indexed citations

11.

Domachowske, Joseph B., Mark M. Blatter, Vijayalakshmi Chandrasekaran, et al.. (2012). A Randomized, Controlled Trial in Children to Assess the Immunogenicity and Safety of a Thimerosal-free Trivalent Seasonal Influenza Vaccine. The Pediatric Infectious Disease Journal. 31(6). 605–615. 3 indexed citations

12.

Glenn, Gregory M., Gale Smith, Louis Fries, et al.. (2012). Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine. Vaccine. 31(3). 524–532. 108 indexed citations

13.

Langley, Joanne M., George Risi, Michael S. Caldwell, et al.. (2011). Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study. The Journal of Infectious Diseases. 203(12). 1729–1738. 65 indexed citations

14.

Langley, Joanne M., Louise Frenette, Linda Ferguson, et al.. (2010). Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults. The Journal of Infectious Diseases. 201(11). 1644–1653. 76 indexed citations

15.

McNeil, Shelly, Scott A. Halperin, Joanne M. Langley, et al.. (2006). A double-blind, randomized phase II trial of the safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults. International Congress Series. 1289. 303–306. 19 indexed citations

16.

Karron, Ruth A., Mark C. Steinhoff, Kanta Subbarao, et al.. (1995). Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age. The Pediatric Infectious Disease Journal. 14(1). 10–16. 53 indexed citations

17.

Steinhoff, M. C., Louis Fries, Ruth A. Karron, M L Clements, & Brian R. Murphy. (1993). Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children. Journal of Clinical Microbiology. 31(4). 836–838. 35 indexed citations

18.

Frank, Michael M. & Louis Fries. (1991). The role of complement in inflammation and phagocytosis. Immunology Today. 12(9). 322–326. 372 indexed citations

19.

Malbrán, Alejandro, Carl H. Hammer, Michael M. Frank, & Louis Fries. (1988). Acquired angioedema: Observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor. Journal of Allergy and Clinical Immunology. 81(6). 1199–1204. 45 indexed citations

20.

Joiner, Keith A., Louis Fries, & Michael M. Frank. (1987). Studies of antibody and complement function in host defense against bacterial infection. Immunology Letters. 14(3). 197–202. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact